Sharps disposal: difference between revisions
Diff·revision 6 → 7·08:33, 30 May 2026
Difference between revision 6 and revision 7 of Sharps disposal. 7 lines changed; the page grew by 1,192 bytes.
| Revision 6 — 00:44, 28 May 2026 A1c_Alder (talk) expand §Scope and definitions 8,240 bytes +1,675 | Revision 7 — 08:33, 30 May 2026 RetinopathyRex (talk) add the preservative point: unpreserved diluent changes the interval 9,432 bytes +1,192 | ||
|---|---|---|---|
| 1 | {{Infobox concept | 1 | {{Infobox concept |
| 2 | | name = Sharps disposal | 2 | | name = Sharps disposal |
| + | 3 | | image = syringe.svg | |
| + | 4 | | caption = A used needle is a sharp from the moment of withdrawal. Container standards address puncture resistance, aperture geometry and irreversible closure. | |
| 3 | | Waste class = Infectious sharps waste | 5 | | Waste class = Infectious sharps waste |
| 4 | | United Nations transport code = UN 3291 | 6 | | United Nations transport code = UN 3291 |
| ⋮ | ⋮ | ||
| 31 | The classification consequence of contamination with a medicinal product is significant and often overlooked. A needle used to inject a medicine is not merely infectious waste; it is infectious waste contaminated with a pharmaceutical, and in the European classification scheme that changes the applicable waste code and therefore the permitted treatment. Codes in chapter 18 of the European List of Waste distinguish waste whose collection and disposal is subject to special requirements in order to prevent infection — 18 01 03*, an absolute hazardous entry — from other clinical waste, and separate entries exist for cytotoxic and cytostatic medicines.{{r|htm0701}} | 33 | The classification consequence of contamination with a medicinal product is significant and often overlooked. A needle used to inject a medicine is not merely infectious waste; it is infectious waste contaminated with a pharmaceutical, and in the European classification scheme that changes the applicable waste code and therefore the permitted treatment. Codes in chapter 18 of the European List of Waste distinguish waste whose collection and disposal is subject to special requirements in order to prevent infection — 18 01 03*, an absolute hazardous entry — from other clinical waste, and separate entries exist for cytotoxic and cytostatic medicines.{{r|htm0701}} |
| 32 | 34 | ||
| + | 35 | Sharps generated outside healthcare — by self-administration at home, by people who inject drugs, by veterinary use — fall outside occupational frameworks entirely and are addressed, where they are addressed at all, through municipal waste law and voluntary schemes. This is the principal reason authoritative guidance for a domestic user is harder to locate than the equivalent guidance for a hospital.{{r|fda_sharps}} | |
| + | 36 | ||
| 33 | == Hazard basis == | 37 | == Hazard basis == |
| 34 | The evidence base for sharps regulation is the epidemiology of occupational percutaneous injury, which is unusually well characterised because it has been under structured surveillance in several countries for decades. | 38 | The evidence base for sharps regulation is the epidemiology of occupational percutaneous injury, which is unusually well characterised because it has been under structured surveillance in several countries for decades. |
| ⋮ | ⋮ | ||
| 46 | Injury surveillance adds a second dimension: when injuries occur. Reports from the EPINet surveillance network and from national schemes consistently find that a substantial fraction of injuries occur after use and before disposal — during device disassembly, during transfer to a container, and from sharps left in unexpected places such as bedding, laundry or waste bags. Injuries during disposal itself, including from overfilled containers and from attempts to force a sharp into a full container, form a recognised subgroup.{{r|epinet,elder2006}} | 50 | Injury surveillance adds a second dimension: when injuries occur. Reports from the EPINet surveillance network and from national schemes consistently find that a substantial fraction of injuries occur after use and before disposal — during device disassembly, during transfer to a container, and from sharps left in unexpected places such as bedding, laundry or waste bags. Injuries during disposal itself, including from overfilled containers and from attempts to force a sharp into a full container, form a recognised subgroup.{{r|epinet,elder2006}} |
| 47 | 51 | ||
| + | 52 | This distribution is why the regulatory response is directed at the interval between use and containment rather than at the moment of injection. The prohibition on recapping needles by hand, the requirement that a container be available at the point of use, and the fill-line requirement all address that interval.{{r|osha1910,eu2010}} | |
| + | 53 | ||
| 48 | == References == | 54 | == References == |
| 49 | {{reflist}} | 55 | {{reflist}} |
| ⋮ | ⋮ | ||
| 52 | <ref name="osha1910">Occupational Safety and Health Administration. ''Bloodborne Pathogens'', 29 CFR 1910.1030, as amended by the Needlestick Safety and Prevention Act (2001). United States Department of Labor.</ref> | 58 | <ref name="osha1910">Occupational Safety and Health Administration. ''Bloodborne Pathogens'', 29 CFR 1910.1030, as amended by the Needlestick Safety and Prevention Act (2001). United States Department of Labor.</ref> |
| 53 | <ref name="mmwr2001">Centers for Disease Control and Prevention. "Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis." ''MMWR Recommendations and Reports'' 50(RR-11):1–52 (2001).</ref> | 59 | <ref name="mmwr2001">Centers for Disease Control and Prevention. "Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis." ''MMWR Recommendations and Reports'' 50(RR-11):1–52 (2001).</ref> |
| + | 60 | <ref name="eu2010">Council Directive 2010/32/EU of 10 May 2010 implementing the Framework Agreement on prevention from sharp injuries in the hospital and healthcare sector. ''Official Journal of the European Union'' L 134:66–72.</ref> | |
| 54 | <ref name="who2015sharps">World Health Organization. ''WHO Guideline on the Use of Safety-Engineered Syringes for Intramuscular, Intradermal and Subcutaneous Injections in Health Care Settings''. Geneva (2015).</ref> | 61 | <ref name="who2015sharps">World Health Organization. ''WHO Guideline on the Use of Safety-Engineered Syringes for Intramuscular, Intradermal and Subcutaneous Injections in Health Care Settings''. Geneva (2015).</ref> |
| 55 | <ref name="elder2006">Elder A, Paterson C. "Sharps injuries in UK health care: a review of injury rates, viral transmission and potential efficacy of safety devices." ''Occupational Medicine'' 56(8):566–574 (2006).</ref> | 62 | <ref name="elder2006">Elder A, Paterson C. "Sharps injuries in UK health care: a review of injury rates, viral transmission and potential efficacy of safety devices." ''Occupational Medicine'' 56(8):566–574 (2006).</ref> |